Glipizide

Product NDC
82868-025
11-digit product format
828680025
Labeler code
82868
Product ID
82868-025_46dc8f32-692a-a243-e063-6394a90a19f8
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Glipizide
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Labeler
Northwind Health Company, LLC
Application
ANDA206928
Marketing category
ANDA
Marketing start
2023-11-08
Substance
GLIPIZIDE
Active strength
5 mg/1
Pharmacologic classes
Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A206928-001GLIPIZIDEGLIPIZIDE2.5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-12
A206928-002GLIPIZIDEGLIPIZIDE5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-12
A206928-003GLIPIZIDEGLIPIZIDE10MGTABLET, EXTENDED RELEASE / ORALAB2017-05-12

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
A206928-001AB
A206928-002AB
A206928-003AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A206928-001GLIPIZIDE2.5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-1284e616aacf4f…
2026-09-14 22:38:342026-08A206928-002GLIPIZIDE5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-1284e616aacf4f…
2026-09-14 22:38:342026-08A206928-003GLIPIZIDE10MGTABLET, EXTENDED RELEASE / ORALAB2017-05-1284e616aacf4f…
2026-08-18 06:07:402026-07A206928-001GLIPIZIDE2.5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-12caaa826d4ba7…
2026-08-18 06:07:402026-07A206928-002GLIPIZIDE5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-12caaa826d4ba7…
2026-08-18 06:07:402026-07A206928-003GLIPIZIDE10MGTABLET, EXTENDED RELEASE / ORALAB2017-05-12caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A206928-001GLIPIZIDE2.5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-12011fe1cb6892…
2026-02-19 14:30 UTC2026-02A206928-002GLIPIZIDE5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-12011fe1cb6892…
2026-02-19 14:30 UTC2026-02A206928-003GLIPIZIDE10MGTABLET, EXTENDED RELEASE / ORALAB2017-05-12011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A206928-001GLIPIZIDE2.5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-1231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A206928-002GLIPIZIDE5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-1231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A206928-003GLIPIZIDE10MGTABLET, EXTENDED RELEASE / ORALAB2017-05-1231067a03dcf5…
2025-08-23 18:47 UTC2025-08A206928-001GLIPIZIDE2.5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-126a471c1ec25d…
2025-08-23 18:47 UTC2025-08A206928-002GLIPIZIDE5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-126a471c1ec25d…
2025-08-23 18:47 UTC2025-08A206928-003GLIPIZIDE10MGTABLET, EXTENDED RELEASE / ORALAB2017-05-126a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A206928-001GLIPIZIDE2.5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-12fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A206928-002GLIPIZIDE5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-12fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A206928-003GLIPIZIDE10MGTABLET, EXTENDED RELEASE / ORALAB2017-05-12fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A206928-001GLIPIZIDE2.5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-12b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A206928-002GLIPIZIDE5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-12b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A206928-003GLIPIZIDE10MGTABLET, EXTENDED RELEASE / ORALAB2017-05-12b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A206928-001GLIPIZIDE2.5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-1203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A206928-002GLIPIZIDE5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-1203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A206928-003GLIPIZIDE10MGTABLET, EXTENDED RELEASE / ORALAB2017-05-1203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A206928-001GLIPIZIDE2.5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-122680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A206928-002GLIPIZIDE5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-122680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A206928-003GLIPIZIDE10MGTABLET, EXTENDED RELEASE / ORALAB2017-05-122680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A206928-001GLIPIZIDE2.5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-125bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A206928-002GLIPIZIDE5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-125bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A206928-003GLIPIZIDE10MGTABLET, EXTENDED RELEASE / ORALAB2017-05-125bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A206928-001GLIPIZIDE2.5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-12d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A206928-002GLIPIZIDE5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-12d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A206928-003GLIPIZIDE10MGTABLET, EXTENDED RELEASE / ORALAB2017-05-12d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A206928-001GLIPIZIDE2.5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-12d06236e962d9…
2024-10-29 15:01 UTC2024-10A206928-002GLIPIZIDE5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-12d06236e962d9…
2024-10-29 15:01 UTC2024-10A206928-003GLIPIZIDE10MGTABLET, EXTENDED RELEASE / ORALAB2017-05-12d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A206928-001GLIPIZIDE2.5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-1279d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A206928-002GLIPIZIDE5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-1279d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A206928-003GLIPIZIDE10MGTABLET, EXTENDED RELEASE / ORALAB2017-05-1279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A206928-001GLIPIZIDE2.5MGTABLET, EXTENDED RELEASE / ORALAB2017-05-12301d65b070ca…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A206928-001AB184e616aacf4f…
2026-09-14 22:38:342026-08A206928-002AB184e616aacf4f…
2026-09-14 22:38:342026-08A206928-003AB184e616aacf4f…
2026-08-18 06:07:402026-07A206928-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A206928-002AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A206928-003AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A206928-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A206928-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A206928-003AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A206928-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A206928-002AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A206928-003AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A206928-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A206928-002AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A206928-003AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A206928-001AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A206928-002AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A206928-003AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A206928-001AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A206928-002AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A206928-003AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A206928-001AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A206928-002AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A206928-003AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A206928-001AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A206928-002AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A206928-003AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A206928-001AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A206928-002AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A206928-003AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A206928-001AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A206928-002AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A206928-003AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A206928-001AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A206928-002AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A206928-003AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A206928-001AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A206928-002AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A206928-003AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A206928-001AB1301d65b070ca…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Glipizide
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
GLIPIZIDE5 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
X7WDT95N5CInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
314006Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
0a1e1152-ade7-2092-e063-6394a90a99e7Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
ec4adfb0-aabc-95b9-ad07-5cb8f8533a09Product name220250625
b1de1ca9-d9db-4f4b-2103-09e2014d30d5Product name520180912
2dee091b-3b8c-d27a-b1ba-fcb0d32e776aProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
82868-025-30Glipizide30 in 1 BOTTLE, PLASTICTABLET, EXTENDED RELEASE303
82868-025-90Glipizide90 in 1 BOTTLE, PLASTICTABLET, EXTENDED RELEASE903

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
82868-025GLIPIZIDE TABLET, EXTENDED RELEASE [NORTHWIND PHARMACEUTICALS, LLC]2Current NDC, 2 package rows20240127_0a1e1152-ade7-2092-e063-6394a90a99e7.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 13 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GlipizideGLIPIZIDEREMEDYREPACK INC.667dd68a-d3e7-4b50-bd0a-d17783a090d52026-08-27Warnings, Adverse reactionsExact identifier
application applno (ANDA): 206928
application number: ANDA206928
GlipizideGLIPIZIDESt. Mary's Medical Park Pharmacy1b2ef6e2-5e7c-761e-e063-6294a90addd02026-06-22Warnings, Adverse reactionsExact identifier
application applno (ANDA): 206928
application number: ANDA206928
GlipizideGLIPIZIDEREMEDYREPACK INC.0df8f606-97b3-463c-a132-338cf4630a712026-06-10Warnings, Adverse reactionsExact identifier
application applno (ANDA): 206928
application number: ANDA206928
GlipizideGLIPIZIDESt. Mary's Medical Park Pharmacy0ccc17ca-fff8-0449-e063-6294a90af36d2026-06-03Warnings, Adverse reactionsExact identifier
application applno (ANDA): 206928
application number: ANDA206928
GlipizideGLIPIZIDEBryant Ranch Prepack2aa01a7e-a703-426f-9cd3-70b88d0a8e7f2026-05-13Warnings, Adverse reactionsExact identifier
application applno (ANDA): 206928
application number: ANDA206928
GlipizideGLIPIZIDEBryant Ranch Prepackceb86ebb-d00a-4261-90ad-8751e799d93c2026-04-20Warnings, Adverse reactionsExact identifier
application applno (ANDA): 206928
application number: ANDA206928
GlipizideGLIPIZIDEBryant Ranch Prepack4afa67b2-7f86-4189-93a5-6a605f74540d2026-04-09Warnings, Adverse reactionsExact identifier
application applno (ANDA): 206928
application number: ANDA206928
GlipizideGLIPIZIDEAurobindo Pharma Limited84794a52-b717-488c-8533-6425c83d405f2026-01-08Warnings, Adverse reactionsExact identifier
application applno (ANDA): 206928
application number: ANDA206928
GlipizideGLIPIZIDENorthwind Health Company, LLC0a1e1152-ade7-2092-e063-6394a90a99e72025-12-26Warnings, Adverse reactionsExact identifier
application applno (ANDA): 206928
application number: ANDA206928
ndc (product): 82868-025
GlipizideGLIPIZIDENorthwind Health Company, LLC0effd04d-172c-5d8c-e063-6294a90a93f42025-12-26Warnings, Adverse reactionsExact identifier
application applno (ANDA): 206928
application number: ANDA206928
GlipizideGLIPIZIDEAmerican Health Packagingaaf029d3-027e-4ae8-8ec5-3a4c16f9bd282025-04-24Warnings, Adverse reactionsExact identifier
application applno (ANDA): 206928
application number: ANDA206928
GlipizideGLIPIZIDEA-S Medication Solutions08b01608-73c2-45e0-8de4-c6c4012611522023-10-23Warnings, Adverse reactionsExact identifier
application applno (ANDA): 206928
application number: ANDA206928
GlipizideGLIPIZIDEA-S Medication Solutions695c178f-77f0-451e-b718-72b65e495b7e2023-10-18Warnings, Adverse reactionsExact identifier
application applno (ANDA): 206928
application number: ANDA206928

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
314006glipiZIDE 5 MG 24HR Extended Release Oral TabletPSN0a1e1152-ade7-2092-e063-6394a90a99e73
31400624 HR glipizide 5 MG Extended Release Oral TabletSCD0a1e1152-ade7-2092-e063-6394a90a99e73
314006glipizide ER 5 MG 24 HR Extended Release Oral TabletSY0a1e1152-ade7-2092-e063-6394a90a99e73
314006glipizide XL 5 MG 24 HR Extended Release Oral TabletSY0a1e1152-ade7-2092-e063-6394a90a99e73

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
82868-025-308286800253030 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82868-025-30) 2024-01-03NoNoCurrent
82868-025-908286800259090 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82868-025-90) 2023-11-08NoNoCurrent